Market News

/

Biotech

/

Regulatory

Regulatory

Infant Botulism Outbreak Linked to Nara Organics Powdered Formula

June 13, 2026

Biotech

Regulatory

Key Facts

Signal Type

Regulatory

Industry

Biotech

Companies

Nara Organics

Date

June 13, 2026

What Happened

Nara Organics Whole Milk Organic Powdered Infant Formula has been linked to three cases of infant botulism across California, Pennsylvania, and Washington. The FDA and CDC are investigating, and Nara Organics has initiated a recall of the product, which was distributed nationally through Target and its website.

Who Is Affected

The recall affects consumers who purchased Nara Organics-brand powdered infant formula between July 2025 and June 2026. Three infants have been hospitalized due to botulism, with symptoms including constipation, poor feeding, and difficulty breathing.

Market Impact

  • Nara Organics Whole Milk Organic Powdered Infant Formula makes up less than 1% of the U.S. infant formula market.
  • The recall does not create shortage concerns but may impact consumer trust in the brand.
  • Competitors may see an opportunity to position their products as safer alternatives.

What to Watch

Monitor the FDA's ongoing investigation and the results of formula testing. Watch for shifts in consumer behavior and potential market opportunities for competitors. Stay updated on any further recalls or regulatory actions.

Source:

fda.gov

Get biotech signals in your CRM

FDA approvals and rejections, clinical trial results, pharma M&A, drug recalls, and funding rounds.

Book a 15 min call
Dominykas Rukas - Revenanas